Marti Lecina

Title: Marti Lecina: Innovator in Stem Cell Culture Technology

Introduction

Marti Lecina is a prominent inventor based in Singapore, known for his contributions to the field of stem cell culture technology. With a total of 3 patents to his name, Lecina has made significant strides in enhancing the methods used for propagating and differentiating stem cells.

Latest Patents

One of Lecina's latest patents focuses on microcarriers for stem cell culture. This innovation discloses a particle that comprises a matrix coated with a positive charge, designed to facilitate the aggregation of primate or human stem cells. The particle can take the form of an elongate, cylindrical, or rod-shaped structure, with dimensions ranging from 50 µm to 400 µm in length and a cross-sectional dimension between 20 µm and 30 µm. Additionally, it can also be a compact or spherical particle, sized between 20 µm and 120 µm. The patent outlines a method for propagating primate or human stem cells by allowing them to aggregate and culture for further propagation. Furthermore, it includes a method for long-term suspension culture of human embryonic stem cells (hESCs) using microcarriers coated in Matrigel or hyaluronic acid, as well as a method for differentiating stem cells.

Career Highlights

Marti Lecina is affiliated with the Agency for Science, Technology and Research, where he continues to push the boundaries of scientific research and innovation. His work has been instrumental in advancing the understanding and application of stem cell technology.

Collaborations

Lecina collaborates with notable colleagues, including Steve Oh and Andre Choo, who contribute to the innovative environment at the Agency for Science, Technology and Research.

Conclusion

Marti Lecina's work in stem cell culture technology exemplifies the impact of innovation in the scientific community. His patents not only enhance the methods of stem cell propagation but also pave the way for future advancements in regenerative medicine.